{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:44:48Z","timestamp":1788176688998,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jacep.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T14:27:37Z","timestamp":1570026457000},"page":"1396-1405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation"],"prefix":"10.1016","volume":"5","author":[{"given":"Jorge","family":"Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto C.","family":"Cerrud-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Alviz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiullah","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Cerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Taveras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Grupposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2019.08.010_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2019.08.010_bib2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/europace\/euv315","article-title":"Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II","volume":"17","author":"Chen","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2019.08.010_bib3","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2019.08.010_bib4","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2019.08.010_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10840-013-9793-7","article-title":"Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter","volume":"37","author":"Kaiser","year":"2013","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10840-013-9800-z","article-title":"Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation","volume":"37","author":"Haines","year":"2013","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","article-title":"Feasibility and safety of dabigatran versus warfarin for\u00a0periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"59","author":"Lakkireddy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib8","first-page":"495","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"377","author":"Calkins","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.08.010_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","article-title":"Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"63","author":"Lakkireddy","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCEP.114.001586","article-title":"Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures","volume":"7","author":"Dillier","year":"2014","journal-title":"Circ Arrhyth Electrophysiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euy133","article-title":"Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Romero","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2019.08.010_bib12","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","article-title":"Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial","volume":"40","author":"Hohnloser","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2019.08.010_bib13","first-page":"1598","article-title":"Asymptomatic cerebral infarction during catheter ablation for atrial fibrillation: comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN)","volume":"4","author":"Kimura","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2019.08.010_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jacep.2019.08.010_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jacep.2019.08.010_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jacep.2019.08.010_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1631\/jzus.B1600492","article-title":"Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation","volume":"18","author":"Zhu","year":"2017","journal-title":"J\u00a0Zhejiang Univ Sci B"},{"key":"10.1016\/j.jacep.2019.08.010_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jce.12928","article-title":"Apixaban versus warfarin for the prevention of periprocedural cerebral thromboembolism in atrial fibrillation ablation: multicenter prospective randomized study","volume":"27","author":"Kuwahara","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib20","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation","volume":"39","author":"Kirchhof","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2019.08.010_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M18-0992","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"170","author":"Turagam","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacep.2019.08.010_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10840-016-0221-7","volume":"48","author":"Zhao","year":"2017","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40267-018-0561-8","article-title":"Andexanet\u00a0alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA","volume":"34","author":"Heo","year":"2018","journal-title":"Drugs Ther Perspect"},{"key":"10.1016\/j.jacep.2019.08.010_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.08.010_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2018.06.024","article-title":"A\u00a0meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation","volume":"270","author":"Zhao","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2019.08.010_bib26","first-page":"A23233","article-title":"Abstract 23233: Asymptomatic cerebral infarction during catheter ablation of atrial fibrillation comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN Study).","volume":"134","author":"Takatsuki","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2019.08.010_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hrthm.2017.09.011","article-title":"An\u00a0updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation","volume":"15","author":"Cardoso","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2019.08.010_bib28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","article-title":"Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study","volume":"12","author":"Di Biase","year":"2015","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X19306413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X19306413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:27:25Z","timestamp":1762500445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X19306413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2405500X19306413"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2019.08.010","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}